Wednesday, June 22, 2016

BRIEF-Agenus Inc starts phase 1/2 clinical trial of anti-GITR agonist antibody

* Expect to initiate additional clinical studies with

antibodies and immuno-oncology leads from comprehensive pipeline

in next twelve months

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)